FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR
A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHANG, Ke XU, Lingling JIANG, Lei JIN, Xian XU, Yuan ZHANG, Yuxing SHOU, Jianyong FENG, Zhiyong WU, Danyi QIAO, Zhi ZHANG, Shuyun ZHANG, Yi |
| description | A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3919490A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3919490A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3919490A13</originalsourceid><addsrcrecordid>eNqNyr0KwjAUQOEsDqK-w32BgKUuGdPkhlw0P6Sp6FSLxEm0UN8fM_gATgcO35rdDJ2RS695Txfu0HWYUIPFjCmoqzqRAhVcDIPXUBkMPUK2FQUDsoeYQkbykFBhzCHBkbyshLyljurYstVjei5l9-uGgcGsLC_zeyzLPN3Lq3xGjK1oxEHsZdP-Qb4Z0DMa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR</title><source>esp@cenet</source><creator>SHANG, Ke ; XU, Lingling ; JIANG, Lei ; JIN, Xian ; XU, Yuan ; ZHANG, Yuxing ; SHOU, Jianyong ; FENG, Zhiyong ; WU, Danyi ; QIAO, Zhi ; ZHANG, Shuyun ; ZHANG, Yi</creator><creatorcontrib>SHANG, Ke ; XU, Lingling ; JIANG, Lei ; JIN, Xian ; XU, Yuan ; ZHANG, Yuxing ; SHOU, Jianyong ; FENG, Zhiyong ; WU, Danyi ; QIAO, Zhi ; ZHANG, Shuyun ; ZHANG, Yi</creatorcontrib><description>A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211208&DB=EPODOC&CC=EP&NR=3919490A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211208&DB=EPODOC&CC=EP&NR=3919490A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHANG, Ke</creatorcontrib><creatorcontrib>XU, Lingling</creatorcontrib><creatorcontrib>JIANG, Lei</creatorcontrib><creatorcontrib>JIN, Xian</creatorcontrib><creatorcontrib>XU, Yuan</creatorcontrib><creatorcontrib>ZHANG, Yuxing</creatorcontrib><creatorcontrib>SHOU, Jianyong</creatorcontrib><creatorcontrib>FENG, Zhiyong</creatorcontrib><creatorcontrib>WU, Danyi</creatorcontrib><creatorcontrib>QIAO, Zhi</creatorcontrib><creatorcontrib>ZHANG, Shuyun</creatorcontrib><creatorcontrib>ZHANG, Yi</creatorcontrib><title>FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR</title><description>A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUQOEsDqK-w32BgKUuGdPkhlw0P6Sp6FSLxEm0UN8fM_gATgcO35rdDJ2RS695Txfu0HWYUIPFjCmoqzqRAhVcDIPXUBkMPUK2FQUDsoeYQkbykFBhzCHBkbyshLyljurYstVjei5l9-uGgcGsLC_zeyzLPN3Lq3xGjK1oxEHsZdP-Qb4Z0DMa</recordid><startdate>20211208</startdate><enddate>20211208</enddate><creator>SHANG, Ke</creator><creator>XU, Lingling</creator><creator>JIANG, Lei</creator><creator>JIN, Xian</creator><creator>XU, Yuan</creator><creator>ZHANG, Yuxing</creator><creator>SHOU, Jianyong</creator><creator>FENG, Zhiyong</creator><creator>WU, Danyi</creator><creator>QIAO, Zhi</creator><creator>ZHANG, Shuyun</creator><creator>ZHANG, Yi</creator><scope>EVB</scope></search><sort><creationdate>20211208</creationdate><title>FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR</title><author>SHANG, Ke ; XU, Lingling ; JIANG, Lei ; JIN, Xian ; XU, Yuan ; ZHANG, Yuxing ; SHOU, Jianyong ; FENG, Zhiyong ; WU, Danyi ; QIAO, Zhi ; ZHANG, Shuyun ; ZHANG, Yi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3919490A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHANG, Ke</creatorcontrib><creatorcontrib>XU, Lingling</creatorcontrib><creatorcontrib>JIANG, Lei</creatorcontrib><creatorcontrib>JIN, Xian</creatorcontrib><creatorcontrib>XU, Yuan</creatorcontrib><creatorcontrib>ZHANG, Yuxing</creatorcontrib><creatorcontrib>SHOU, Jianyong</creatorcontrib><creatorcontrib>FENG, Zhiyong</creatorcontrib><creatorcontrib>WU, Danyi</creatorcontrib><creatorcontrib>QIAO, Zhi</creatorcontrib><creatorcontrib>ZHANG, Shuyun</creatorcontrib><creatorcontrib>ZHANG, Yi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHANG, Ke</au><au>XU, Lingling</au><au>JIANG, Lei</au><au>JIN, Xian</au><au>XU, Yuan</au><au>ZHANG, Yuxing</au><au>SHOU, Jianyong</au><au>FENG, Zhiyong</au><au>WU, Danyi</au><au>QIAO, Zhi</au><au>ZHANG, Shuyun</au><au>ZHANG, Yi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR</title><date>2021-12-08</date><risdate>2021</risdate><abstract>A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3919490A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A39%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHANG,%20Ke&rft.date=2021-12-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3919490A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |